Emily Janvey

Director/Board Member chez Abingworth Management, Inc.

Profil

Emily Janvey joined Abingworth in April 2023 as a Managing Director based in our Boston office.
Emily focusses on Abingworth’s Clinical Co-Development practice where she is responsible for sourcing and the execution of deals.
Previously, Emily was Health Care Sector Head within the Investment Strategy Group at ICONIQ and prior to joining ICONIQ, was a Director on KKR’s America’s Health Care Private Equity team investing across the health care landscape and with a focus on large cap private equity, growth equity and non-dilutive financings.
Emily was previously a VP at Sixth Street Partners where she provided alternative financing to pharma and biotech.
Emily started her career as a consultant in the health care practice at McKinsey and Company.
Emily has served on the boards of companies across health care sectors and stages.
Emily earned her MD and MBA from the University of Pennsylvania and her BA in neuroscience from Hamilton College.

Postes actifs de Emily Janvey

Sociétés	Poste	Début
Abingworth Management, Inc.	Director/Board Member	01/04/2023

Anciens postes connus de Emily Janvey

Sociétés	Poste	Fin
ICONIQ Capital (Private Equity)	Private Equity Investor	01/04/2023
Kohlberg Kravis Roberts & Co. LP	Private Equity Investor	01/01/2020
Arbor Pharmaceuticals LLC	Director/Board Member	-
Headlands Research, Inc.	Director/Board Member	-
McKinsey & Co., Inc.	Corporate Officer/Principal	-

Formation de Emily Janvey

Hamilton College (New York)	Undergraduate Degree
The Wharton School of the University of Pennsylvania	Doctorate Degree